A meta-analysis of the relationship between circulating microRNA-155 and coronary artery disease.

<h4>Objective</h4>Coronary artery disease (CAD) is a leading cause of death worldwide. Many studies in China and abroad have reported an association between the expression level of microRNA-155 and CAD; however, the results remain controversial. We aimed to comprehensively investigate th...

Full description

Bibliographic Details
Main Authors: Tao Ran, Jinyao Chen, Yu Cheng, Min Zhang, Min Mao, Rui Xiang, Zhong Zuo, Jing Chang, Baoru Han, Kanghua Ma
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0274277
_version_ 1797838610501730304
author Tao Ran
Jinyao Chen
Yu Cheng
Min Zhang
Min Mao
Rui Xiang
Zhong Zuo
Jing Chang
Baoru Han
Kanghua Ma
author_facet Tao Ran
Jinyao Chen
Yu Cheng
Min Zhang
Min Mao
Rui Xiang
Zhong Zuo
Jing Chang
Baoru Han
Kanghua Ma
author_sort Tao Ran
collection DOAJ
description <h4>Objective</h4>Coronary artery disease (CAD) is a leading cause of death worldwide. Many studies in China and abroad have reported an association between the expression level of microRNA-155 and CAD; however, the results remain controversial. We aimed to comprehensively investigate this association based on a meta-analysis.<h4>Methods</h4>We first systematically searched eight Chinese and English databases, including China National Knowledge Infrastructure, Wanfang, China Science and Technology Journal Database, PubMed, Web of Science, Embase, Google Scholar, and Cochrane Library, to identify studies concerning the relationship between microRNA-155 levels and CAD published before February 7, 2021. The quality of the literature was assessed by the Newcastle-Ottawa Scale (NOS). Meta-analysis was performed using a random-effects model to calculate the standard mean difference with a 95% confidence interval (CI).<h4>Results</h4>Sixteen articles with a total of 2069 patients with CAD and 1338 controls were included. All the articles were of high quality according to the NOS. The meta-analysis showed that the mean level of microRNA-155 was significantly lower in patients with CAD than in controls. Based on subgroup analyses, the level of microRNA-155 in the plasma of CAD patients and in acute myocardial infarction (AMI) patients was significantly lower than that in controls, whereas this level in CAD patients with mild stenosis was significantly higher than that in controls.<h4>Conclusion</h4>Our study indicates that the expression level of circulating microRNA-155 in patients with CAD is lower than that in a non-CAD group, suggesting a new possible reference index for the diagnosis and monitoring of patients with CAD.
first_indexed 2024-04-09T15:44:43Z
format Article
id doaj.art-e547652814334d10b9d73abb526ec8e8
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-09T15:44:43Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e547652814334d10b9d73abb526ec8e82023-04-27T05:31:30ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01184e027427710.1371/journal.pone.0274277A meta-analysis of the relationship between circulating microRNA-155 and coronary artery disease.Tao RanJinyao ChenYu ChengMin ZhangMin MaoRui XiangZhong ZuoJing ChangBaoru HanKanghua Ma<h4>Objective</h4>Coronary artery disease (CAD) is a leading cause of death worldwide. Many studies in China and abroad have reported an association between the expression level of microRNA-155 and CAD; however, the results remain controversial. We aimed to comprehensively investigate this association based on a meta-analysis.<h4>Methods</h4>We first systematically searched eight Chinese and English databases, including China National Knowledge Infrastructure, Wanfang, China Science and Technology Journal Database, PubMed, Web of Science, Embase, Google Scholar, and Cochrane Library, to identify studies concerning the relationship between microRNA-155 levels and CAD published before February 7, 2021. The quality of the literature was assessed by the Newcastle-Ottawa Scale (NOS). Meta-analysis was performed using a random-effects model to calculate the standard mean difference with a 95% confidence interval (CI).<h4>Results</h4>Sixteen articles with a total of 2069 patients with CAD and 1338 controls were included. All the articles were of high quality according to the NOS. The meta-analysis showed that the mean level of microRNA-155 was significantly lower in patients with CAD than in controls. Based on subgroup analyses, the level of microRNA-155 in the plasma of CAD patients and in acute myocardial infarction (AMI) patients was significantly lower than that in controls, whereas this level in CAD patients with mild stenosis was significantly higher than that in controls.<h4>Conclusion</h4>Our study indicates that the expression level of circulating microRNA-155 in patients with CAD is lower than that in a non-CAD group, suggesting a new possible reference index for the diagnosis and monitoring of patients with CAD.https://doi.org/10.1371/journal.pone.0274277
spellingShingle Tao Ran
Jinyao Chen
Yu Cheng
Min Zhang
Min Mao
Rui Xiang
Zhong Zuo
Jing Chang
Baoru Han
Kanghua Ma
A meta-analysis of the relationship between circulating microRNA-155 and coronary artery disease.
PLoS ONE
title A meta-analysis of the relationship between circulating microRNA-155 and coronary artery disease.
title_full A meta-analysis of the relationship between circulating microRNA-155 and coronary artery disease.
title_fullStr A meta-analysis of the relationship between circulating microRNA-155 and coronary artery disease.
title_full_unstemmed A meta-analysis of the relationship between circulating microRNA-155 and coronary artery disease.
title_short A meta-analysis of the relationship between circulating microRNA-155 and coronary artery disease.
title_sort meta analysis of the relationship between circulating microrna 155 and coronary artery disease
url https://doi.org/10.1371/journal.pone.0274277
work_keys_str_mv AT taoran ametaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT jinyaochen ametaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT yucheng ametaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT minzhang ametaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT minmao ametaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT ruixiang ametaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT zhongzuo ametaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT jingchang ametaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT baoruhan ametaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT kanghuama ametaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT taoran metaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT jinyaochen metaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT yucheng metaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT minzhang metaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT minmao metaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT ruixiang metaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT zhongzuo metaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT jingchang metaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT baoruhan metaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease
AT kanghuama metaanalysisoftherelationshipbetweencirculatingmicrorna155andcoronaryarterydisease